Medy-Tox (XKRX:086900) Days Sales Outstanding : 73.67 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Days Sales Outstanding?

Medy-Tox's average Accounts Receivable for the three months ended in Dec. 2023 was ₩54,902 Mil. Medy-Tox's Revenue for the three months ended in Dec. 2023 was ₩68,004 Mil. Hence, Medy-Tox's Days Sales Outstanding for the three months ended in Dec. 2023 was 73.67.

The historical rank and industry rank for Medy-Tox's Days Sales Outstanding or its related term are showing as below:

XKRX:086900' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.83 Med: 68.62 Max: 117.48
Current: 77.64

During the past 13 years, Medy-Tox's highest Days Sales Outstanding was 117.48. The lowest was 53.83. And the median was 68.62.

XKRX:086900's Days Sales Outstanding is ranked worse than
53.19% of 893 companies
in the Biotechnology industry
Industry Median: 73.24 vs XKRX:086900: 77.64

Medy-Tox's Days Sales Outstanding declined from Dec. 2022 (76.04) to Dec. 2023 (73.67).

Medy-Tox Days Sales Outstanding Historical Data

The historical data trend for Medy-Tox's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Days Sales Outstanding Chart

Medy-Tox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

105.55

117.48

62.06

68.94

87.08

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															76.04	91.22	70.82	69.51	73.67

Competitive Comparison of Medy-Tox's Days Sales Outstanding

For the Biotechnology subindustry, Medy-Tox's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medy-Tox's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medy-Tox's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medy-Tox's Days Sales Outstanding falls into.

Medy-Tox Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medy-Tox's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (44998.252	+	60507.719)	/	2 )	/	221120.683	*	365
=	52752.9855					/	221120.683	*	365
=	87.08

Medy-Tox's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (49297.018	+	60507.719)	/	2 )	/	68003.639	*	365 / 4
=	54902.3685					/	68003.639	*	365 / 4
=	73.67

Medy-Tox (XKRX:086900) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medy-Tox Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines